Orange Book Blog

American Conference Institute will be holding its 13th annual "Maximizing Pharmaceutical Patent Life Cycles" conference in New York City on October 10-11.  There have many important developments in pharmaceutical patent law over the last year–from use codes to Myriad to the safe harbor–and this conference will bring you up to speed.

The conference agenda includes the following talks:

• From Product Development to Patent Portfolio Management:  Patent Life Cycle Strategies for a Post-AIA World
• An Industry Perspective on Implementation of the AIA, New PTO Proceedings, and Their Collective Impact on Life Cycle Management
• Preparing for the Implementation of the FDA's Biosimilars Pathway and its Effects on Life Cycle Planning
• REMS Studies and Generic Entry:  Exploring the Latest Regulatory Conundrums Affecting Pharmaceutical Patent Life Cycle Strategies
• Personalized Medicine and Patent Life Cycle Considerations in Light of Prometheus and Other Recent Challenges to Subject Matter Patentability, Written Description, and More
• Employing Strategies to Avoid Findings of Obviousness:  Legal Analysis and Practical Applications for Brand Names and Generics
• Inequitable Conduct Post-Therasense and How it Impacts Life Cycle Planning
• USPTO Keynote:  The Brave New World of Patent Reform and its Impact on Pharmaceutical Patents
• Understanding How Caraco has Redefined the Relationship Between Pharmaceutical Patents, Labels, and Use Codes
• Analyzing Method Claims and the Madness Over Recent and Pending Inducement and Divided Infringement Cases
• Exclusivities and Forfeitures:  New Developments, Controversies and Related Concerns
• An Update on FDA Activities Impacting Pharmaceutical Patent Life Cycle Planning
• Safe Harbor or Stormy Port?  Calming the Legal Tempest Left by Proveris
• Understanding the Importance of Rx to OTC Switches to the Future of Pharmaceutical Patent Life Cycle Management

In addition to the two-day main conference, ACI is offering two pre-conference workshops on October 9th:  Assessing the Impact of New PTO Procedures Under the AIA on Hatch-Waxman Strategies Relative to Patent Life Cycle Management; and Basic Training in the Essentials of Patent Term Adjustment and Patent Term Restoration for Patent Lawyers Serving the Biopharmaceutical Industry.

Orange Book Blog is a media partner of the conference, so readers are eligible for a $200 discount by using registration code OBB 200.  For more information or to register, please visit the conference website.